Former Senator Norm Coleman Joins OpenAI's Lobbying Team

Tuesday, 12 March 2024, 10:00

OpenAI has enlisted the expertise of former Senator Norm Coleman to bolster its lobbying efforts surrounding artificial intelligence (AI) research and development. This move comes as part of a broader initiative by the company to enhance its presence in the lobbying sphere, signaling a strategic focus on engaging with policymakers and advocating for AI-related policies.
https://store.livarava.com/b7ba1f6e-e057-11ee-9663-5254a2021b2b.jpe
Former Senator Norm Coleman Joins OpenAI's Lobbying Team

OpenAI Strengthens Lobbying Team with Notable Addition

OpenAI has recently expanded its lobbying efforts by hiring Hogan Lovells US LLP to advocate on matters concerning AI research and development. Former Senator Norm Coleman (R-Minn.) will be part of the team involved in these lobbying activities.

Center for AI Safety Action Fund's Engagement

The Center for AI Safety Action Fund has also sought strategic advice from Akin regarding AI-related policies. This move underscores a growing emphasis on AI advocacy within various organizations.

Significant Lobbying Initiatives in Insurance, Health, and Technology Sectors

Several notable companies, including Aflac and Amgen, have engaged lobbying services to address key legislative issues impacting their operations. These developments reflect a broader trend of intensified lobbying activities in the field of technology and healthcare.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe